Ractigen Therapeutics raises over $31M in a funding round led by Guozhong Capital to accelerate clinical development of saRNA therapeutics.
Amount Raised
$31 Million
Round Type
Venture
NantongHealth CareScience And EngineeringInvestors
Description
Ractigen Therapeutics, a Shanghai-based biotechnology company, raised over $31M in funding. This round was led by Guozhong Capital and included various other investors. The funds will be used to advance clinical trials for their saRNA assets. The company has three differentiated assets in clinical-stage development.
Quick answer
Ractigen Therapeutics raised $31 Million in a funding round, dated July 30, 2026. Investors: Snd Financial Holdings, Longmen Capital, IDG Capital, China Everbright Limited, Jolmo Capital, Win Win Capital and Guozhong Capital. Ractigen Therapeutics is based in Nantong, Jiangsu, China.
- How much did Ractigen Therapeutics raise?
- Ractigen Therapeutics raised $31 Million in a funding round on July 30, 2026.
- Who invested in Ractigen Therapeutics?
- Snd Financial Holdings, Longmen Capital, IDG Capital, China Everbright Limited, Jolmo Capital, Win Win Capital and Guozhong Capital are named as investors in this round.
- What does Ractigen Therapeutics do?
- Ractigen Therapeutics was founded in 2017 by pioneers of the RNAa technology including Dr. Long-Cheng Li and his longstanding colleagues Dr. Robert Place and Dr. Moorim Kang.
- Where is Ractigen Therapeutics based and how big is it?
- Ractigen Therapeutics is based in Nantong, Jiangsu, China. Fundz records about 18 employees.
- Who are the decision-makers at Ractigen Therapeutics?
- Fundz holds 1 contact at Ractigen Therapeutics, including the Co-founder, President & CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Health Care around the same time
Companies in the same sectors as Ractigen Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- IMPLICITY raised $41M on September 9, 2026.
- HealthSnap raised $25M (Debt Financing) on August 6, 2026.
- Alzamend Neuro raised $7.5M (Series D) on August 4, 2026.
- RedHill Biopharma Ltd raised $6M (Post-IPO Equity) on June 18, 2026.
- Tandem Health raised $100M (Series B) on September 13, 2026.
- David Protein raised $250M (Series B) on September 13, 2026.
Who to call at Ractigen Therapeutics, and when
A new round usually means Ractigen Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ractigen Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ractigen Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ractigen Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ractigen Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Ractigen Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.